Abbvie Inc (ABBV) is trading -6% lower at $140.275 today.

Abbvie Inc has been trading between a 52-week high of $172.81 and a 52-week low of $101.41. The stock has a market cap of $248 Billion.

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta''s Duchenne Candidate Update
Benzinga 07-29-22

AbbVie Q2 revenue soars on back of blockbuster Humira; sets aside ~$2B for opioid claims
Seeking Alpha 07-29-22

AbbVie Ekes Out Narrow Second-Quarter Beat, Confirms 2022 Outlook
Investor''s Business Daily 07-29-22

AbbVie Stock Slips After Earnings, Charge for Potential Opioid Deal
Barron''s 07-29-22

AbbVie''s Q2 Sales Marginally Shy Of Wall Street Estimates, Confirms Annual Profit Outlook
Benzinga 07-29-22


As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

Chance_Island2704 - 1 upvotes - source
Thanks for the advertisement for my beloved ABBV

jamtradez - 1 upvotes - source
ABBV is in trouble

Chance_Island2704 - 1 upvotes - source
Considering trying to catch the ABBV falling knife